Replies to post #38162 on Biotech Values

[DewDiligence]

>Pfizer announced plans to cut its U.S. sales force by 20%, an acknowledgement that its current model for marketing drugs to doctors is too expensive.<

It’s about time. McKinnell had hinted that he would cut the salesforce, but he never did to any material degree.

This is a good development for some other Big Pharma, who may now decide to make corresponding cuts in their salesforces.

NVS is a notable exception: they are adding 20 % to their U.S. salesforce because they have several big launches and rollouts coming up.

[DewDiligence]

Two companies going in opposite directions:

PFE’s U.S. sales organization is going from 11,000 to 9,000.

NVS’ U.S. sales organization is going from 4,000 to 5,000.

[DewDiligence]

Astonishing factoid:

There is now one drug sales rep for every nine U.S. doctors, compared to one for every 18 in 1996. (Source: Forbes)